Neuronetics, Inc. (STIM)
1.42
-0.16
(-10.13%)
USD |
NASDAQ |
Feb 13, 16:00
1.46
+0.04
(+2.82%)
After-Hours: 20:00
Neuronetics EPS Diluted (Quarterly) : -0.1344 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -1.009 |
| Plus Therapeutics, Inc. | -0.0412 |
| Atossa Therapeutics, Inc. | -1.009 |
| Abeona Therapeutics, Inc. | -0.0952 |
| Cell Source, Inc. | -0.021 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.401M |
| Revenue (Quarterly) | 37.30M |
| Total Expenses (Quarterly) | 46.34M |
| Enterprise Value | 157.36M |
| Gross Profit Margin (Quarterly) | 43.49% |
| Profit Margin (Quarterly) | -25.21% |
| Earnings Yield | -58.10% |
| Normalized Earnings Yield | -58.10 |